EUVIMEDEUVIMED entdecken
Multizentrische StudiePragmatische StudieRandomisierte kontrollierte StudieOpen Access

A Direct-to-Patient Digital Health Program for Lung Cancer Screening

David P Miller, Anna C Snavely, Ajay Dharod, Alison T Brenner, Elena Wright, Lindsay Stradtman, Christina R Bellinger, Richa Bundy, Robert J Volk, Emily Hamburger, Renée M Ferrari, Aliza Randazzo und 1 weitere

JAMA · 2025

DOI: 10.1001/jama.2025.17281 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift JAMA, 2025. Verfasst von David P Miller und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina. Hauptthemen laut MEDLINE: Digital Health, Direct-To-Consumer Screening and Testing, Early Detection of Cancer, Lung Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Screening chest computed tomography (CT) scans reduce lung cancer mortality in high-risk individuals, but less than 20% of eligible individuals are screened in the US.

Objective

To determine whether a direct-to-patient digital health program increases lung cancer screening. Design, Setting, and Participants Randomized clinical trial enrolling individuals aged 50 to 77 years who met Centers for Medicare & Medicaid Services criteria for lung cancer screening between April 18, 2022, and May 30, 2023, at 2 academic health systems in the southeastern US. The date of last follow-up was September 30, 2024.

Interventions

Participants were randomized 1:1 to the mPATH-Lung program, a digital health program delivered outside a clinical visit that included a brief decision aid and option to request a screening appointment (n = 669) or enhanced usual care, in which patients were notified of their lung cancer screening eligibility and advised to speak with their primary care clinician (n = 664). Main Outcomes and Measures The primary outcome was completion of any chest CT within 16 weeks. Secondary outcomes included screening decisions, process measures (screening visits, CT scans ordered), clinical outcomes (lung cancer screening results, lung cancers diagnosed), screening harms, and implementation outcomes.

Results

Electronic invitations were sent to 26 909 individuals with a smoking history in their electronic health record; 3267 completed website eligibility questions and 1333 were deemed eligible and enrolled. The mean age was 60.7 years (SD, 6.8 years); 864 (65%) were female; 232 (17%) were Black and 1054 (79%) were non-Hispanic White; and 621 (47%) had commercial insurance and 595 (45%) had public insurance. Chest CT completion was higher in the mPATH-Lung group than in controls (24.5% [164/669] vs 17.0% [113/664]; odds ratio, 1.6; 95% CI, 1.2-2.1). Among patients who completed screening CT, false-positive results occurred in 12.7% (19/150) of mPATH-Lung participants and 8.4% (8/95) of controls. Invasive procedures were performed in 2.0% (3/150) in the intervention group and 1.1% (1/95) in the control group, with no complications. Conclusions and Relevance Compared with enhanced usual care, a direct-to-patient digital health intervention increased rates of lung cancer screening. Future research should assess the reach and effectiveness of digital lung cancer screening interventions across diverse populations and health care settings. Trial Registration ClinicalTrials.gov Identifier: NCT04083859

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Digital HealthDirect-To-Consumer Screening and TestingEarly Detection of CancerLung NeoplasmsTomography, X-Ray ComputedAgedFemaleHumansMaleMiddle AgedCenters for Medicare and Medicaid Services, U.S.Decision Support TechniquesFollow-Up StudiesMass ScreeningNorth CarolinaPatient PortalsTelemedicine

Autor:innen und Institutionen

  • Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, North Carolina.
  • Division of General Medicine and Clinical Epidemiology, University of North Carolina, Chapel Hill.
  • UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.
  • Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Miller, D. P., Snavely, A. C., Dharod, A., Brenner, A. T., Wright, E., Stradtman, L., Bellinger, C. R., Bundy, R., Volk, R. J., Hamburger, E., Ferrari, R. M., Randazzo, A., & Reuland, D. S. (2025). A Direct-to-Patient Digital Health Program for Lung Cancer Screening. JAMA. https://doi.org/10.1001/jama.2025.17281

Vancouver

Miller DP, Snavely AC, Dharod A, Brenner AT, Wright E, Stradtman L, et al. A Direct-to-Patient Digital Health Program for Lung Cancer Screening. JAMA. 2025. doi:10.1001/jama.2025.17281

BibTeX
@article{Miller2025,
  author = {Miller, David P and Snavely, Anna C and Dharod, Ajay and Brenner, Alison T and Wright, Elena and Stradtman, Lindsay and Bellinger, Christina R and Bundy, Richa and Volk, Robert J and Hamburger, Emily and Ferrari, Renée M and Randazzo, Aliza and Reuland, Daniel S},
  title = {A Direct-to-Patient Digital Health Program for Lung Cancer Screening},
  journal = {JAMA},
  year = {2025},
  doi = {10.1001/jama.2025.17281}
}
Kostenlos starten →